𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines

✍ Scribed by C. Stanciu-Herrera; C. Morgan; L. Herrera

Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
691 KB
Volume
32
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Chimeric, divalent and tetravalent anti-
Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines
✍ Xiao-Yun Liu; Laurentiu M. Pop; Lydia Tsai; Iliodora V. Pop; Ellen S. Vitetta πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 295 KB

## Abstract CD19 is an attractive therapeutic target for treating human B‐cell tumors. In our study, chimeric (c) divalent (cHD37) and tetravalent (cHD37‐DcVV) anti‐CD19 monoclonal antibodies (MAbs) were constructed, expressed and evaluated for their binding to human 19‐positive (CD19^+^) tumor cel

Comparison of the performance of anti-CD
Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line
✍ David J. Flavell; Sue Cooper; Keiko Okayama; Loretta Emery; Sopsamorn U. Flavell πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 930 KB

We have investigated the cytotoxic performance of two different anti-CD7/anti-saporin BsAb's (HB2 x DB7-18 and Ql.l), three anti-CD38/anti-saporin BsAb's (OKT10 x RabSap, OKTlO x DB7-18 and Q4.1) and an anti-CD7 (HB2-Sap) and anti-CD38-saporin (OKTI 0-Sap) immunotoxin for delivering the ribosome ina